Acquisition of the Agilent Cytation C10 confocal imaging reader for enhancing biomedical research excellence at Clemson University
采购 Agilent Cytation C10 共焦成像阅读器,以提高克莱姆森大学的生物医学研究卓越性
基本信息
- 批准号:10798537
- 负责人:
- 金额:$ 29.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAfrican TrypanosomiasisAmebic colitisAntifungal AgentsAntiparasitic AgentsAreaAspergillosisAspergillus fumigatusAssistantshipAwardAzolesBioinformaticsBiologyBiomedical ResearchBioterrorismC10Cardiovascular DiseasesCell SeparationCenters of Research ExcellenceChagas DiseaseClassificationCollaborationsColon CarcinomaCommunicable DiseasesCommunicationComplexCountryCryptococcusDetectionDevelopmentDiagnosisDiseaseDynein ATPaseDysenteryEducational workshopEnvironmentEnvironmental Risk FactorEquipmentEvolutionFacultyFaculty RecruitmentFosteringFundingFungal MeningitisGenomicsGlobal ChangeGoalsGrantHelminthsHost DefenseHumanImageIncidenceInfectionInfrastructureInstitutionInterdisciplinary StudyKnowledgeLeadershipLightMacrophageMalariaMedicalMeningitisMentorsModelingMusculoskeletal DiseasesOxidantsParasitesParasitic DiseasesPhasePilot ProjectsPostdoctoral FellowPovertyProbabilityProgram Research Project GrantsReaderRegulationResearchResearch PersonnelResource AllocationRoleScientistSouth CarolinaStressStrokeStudent recruitmentToxoplasmosisTrainingTrichomonas InfectionsTrypanosomaUnited States National Institutes of HealthUniversitiesVaccinesVirulenceZebrafishbaseclimate changecollegeconfocal imagingcytatedietary supplementsdrug discoveryemerging pathogengraduate studenthuman diseaseimaging facilitiesinnovationinsightlipidomicsmembermultidisciplinaryneglectneglected tropical diseasespathogenprimary amebic meningoencephalitisprogramsrecruitresponseskillssuccesstargeted treatmenttenure tracktissue regenerationtransmission processvector
项目摘要
PROJECT SUMMARY/ABSTRACT
Eukaryotic pathogens are the causative agents of some of the most devastating and intractable diseases of
humans, including malaria, amebic dysentery, African sleeping sickness, Chagas disease, trichomoniasis,
aspergillosis, cryptococcal fungal meningitis, toxoplasmosis and primary amebic meningoencephalitis (PAM).
The global impact of these diseases is immense. It is noteworthy that many of these pathogens are the causative
agents of neglected tropical diseases (NTDs), neglected diseases of poverty (NDPs) and/or are classified as
bioterrorism agents. Importantly, infections caused by eukaryotic pathogens are increasing in the US due to
globalization. The primary goal of this COBRE proposal is to increase the number of NIH-funded scientists in the
state of South Carolina by supporting a world-class research center, the Eukaryotic Pathogens Innovation Center
(EPIC), at Clemson University (CU). The scientific focus of EPIC is a multidisciplinary study of important global
eukaryotic pathogens. EPIC is the first-and-only in the state with a focus on infectious diseases, and the first-
and-only in the country with a focus on eukaryotic pathogens. Four projects from target junior investigators will
be supported. Their projects are 1) Regulation mechanisms of Trypanosome brucei axonemal dynein, 2)
Functional roles of ncRNA, afu-182, in azole response and pathobiology of Aspergillus fumigatus, 3)
Investigating the function of macrophages in the efficacy of anti-fungal drugs in larval zebrafish, and 4) Evaluating
anti-parasitic diazacyclobutenes. These investigators will be matched with external and internal mentors who are
established NIH-funded researchers. The projects will be supported by a well-organized Administrative Core and
two state-of-the-art Scientific Cores in Genomics, and Imaging/Cell Sorting. The center also has a substantial
infrastructure base and significant institutional support. For example, CU will recruit two additional faculty
members and two post-doctoral fellows to expand activities of this center over the course of the project period.
Pledges of graduate assistantships, equipment, and space further exemplify the institutional commitment. The
continuation of this COBRE-funded center will significantly expand research in South Carolina and will facilitate
recruitment, training, and retention of a critical mass of investigators with cross-disciplinary skills in this important
research area.
项目概要/摘要
真核病原体是一些最具破坏性和棘手疾病的病原体
人类,包括疟疾、阿米巴痢疾、非洲昏睡病、恰加斯病、滴虫病、
曲霉病、隐球菌真菌性脑膜炎、弓形虫病和原发性阿米巴脑膜脑炎 (PAM)。
这些疾病的全球影响是巨大的。值得注意的是,许多这些病原体都是致病菌。
被忽视的热带病 (NTD)、被忽视的贫困疾病 (NDP) 和/或被归类为
生物恐怖主义代理人。重要的是,由于以下原因,美国由真核病原体引起的感染正在增加
全球化。 COBRE 提案的主要目标是增加 NIH 资助的科学家数量
南卡罗来纳州通过支持世界一流的研究中心真核病原体创新中心
(EPIC),克莱姆森大学(CU)。 EPIC 的科学重点是对全球重要问题进行多学科研究
真核病原体。 EPIC 是该州第一个也是唯一一个专注于传染病的机构,也是第一个-
并且-仅在专注于真核病原体的国家。目标初级研究人员的四个项目将
得到支持。他们的项目是 1) 布氏锥虫轴丝动力蛋白的调节机制,2)
ncRNA,afu-182,在烟曲霉的唑反应和病理学中的功能作用,3)
研究巨噬细胞在斑马鱼幼体抗真菌药物疗效中的功能,以及4)评估
抗寄生虫二氮杂环丁烯。这些调查员将与外部和内部导师相匹配,他们是
建立了 NIH 资助的研究人员。这些项目将得到组织良好的行政核心和
基因组学和成像/细胞分选两个最先进的科学核心。该中心还拥有大量
基础设施基础和重要的制度支持。例如,CU将额外招聘两名教师
成员和两名博士后研究员,以在项目期间扩大该中心的活动。
研究生助学金、设备和空间的承诺进一步体现了机构的承诺。这
该 COBRE 资助的中心的延续将显着扩大南卡罗来纳州的研究范围,并将促进
在这一重要领域招募、培训和留住足够数量具有跨学科技能的调查人员
研究领域。
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Comparison of cell viability assessment and visualization of Aspergillus niger biofilm with two fluorescent probe staining methods.
使用两种荧光探针染色方法对黑曲霉生物膜的细胞活力评估和可视化进行比较。
- DOI:
- 发表时间:2022-12
- 期刊:
- 影响因子:6.8
- 作者:Shailaja, Aswathy;Bruce, Terri F;Gerard, Patrick;Powell, Rhonda R;Pettigrew, Charles A;Kerrigan, Julia L
- 通讯作者:Kerrigan, Julia L
Draft Genome Sequence of Exophiala Strain HKRS030, a Fungus Capable of Reducing Iron but Not Nitrate.
Exophiala 菌株 HKRS030 的基因组序列草图,一种能够还原铁但不能还原硝酸盐的真菌。
- DOI:
- 发表时间:2023-03-16
- 期刊:
- 影响因子:0.8
- 作者:Burton, Zachary T;Kurtz Jr, Harry D
- 通讯作者:Kurtz Jr, Harry D
Genetic Diversity and Fungicide Sensitivity of Cytospora plurivora on Peach.
桃多食胞孢菌的遗传多样性和杀菌剂敏感性。
- DOI:
- 发表时间:2023-07
- 期刊:
- 影响因子:4.5
- 作者:Baker, Stephen T;Froelich, Martha H;Boatwright, Harriet;Wang, Hehe;Schnabel, Guido;Kerrigan, Julia
- 通讯作者:Kerrigan, Julia
Glucose metabolism in the pathogenic free-living amoebae: Tempting targets for treatment development.
致病性自由生活变形虫中的葡萄糖代谢:治疗开发的诱人目标。
- DOI:
- 发表时间:2024-01
- 期刊:
- 影响因子:3
- 作者:Milanes, Jillian E;Kwain, Samuel;Drawdy, Allyson;Dodson, Laura;Monaghan, Matthew T;Rice, Christopher A;Dominy, Brian N;Whitehead, Daniel C;Morris, James C
- 通讯作者:Morris, James C
Cellulose-based hydrogels towards an antibacterial wound dressing.
基于纤维素的水凝胶用于抗菌伤口敷料。
- DOI:
- 发表时间:2022-12-07
- 期刊:
- 影响因子:6.6
- 作者:Guamba, Esteban;Vispo, Nelson Santiago;Whitehead, Daniel C;Singh, Ajaya Kumar;Santos;Niebieskikwiat, Dario;Zamora;Alexis, Frank
- 通讯作者:Alexis, Frank
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES Culvin MORRIS其他文献
JAMES Culvin MORRIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES Culvin MORRIS', 18)}}的其他基金
Approaches for genetic manipulation of Naegleria fowleri
福氏耐格里虫的基因操作方法
- 批准号:
10641130 - 财政年份:2023
- 资助金额:
$ 29.61万 - 项目类别:
Enolase inhibitors as therapeutic leads for Naegleria fowleri infections
烯醇酶抑制剂作为福氏耐格里阿米巴感染的治疗先导药物
- 批准号:
10739388 - 财政年份:2023
- 资助金额:
$ 29.61万 - 项目类别:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
COBRE:真核病原体创新中心(EPIC)
- 批准号:
10666653 - 财政年份:2022
- 资助金额:
$ 29.61万 - 项目类别:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
COBRE:真核病原体创新中心(EPIC)
- 批准号:
10494462 - 财政年份:2022
- 资助金额:
$ 29.61万 - 项目类别:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
COBRE:真核病原体创新中心(EPIC)
- 批准号:
10666653 - 财政年份:2022
- 资助金额:
$ 29.61万 - 项目类别:
Nutrient sensing and hexokinases in T. brucei
T. brucei 中的营养感应和己糖激酶
- 批准号:
7911534 - 财政年份:2009
- 资助金额:
$ 29.61万 - 项目类别:
Nutrient sensing and hexokinases in T. brucei
T. brucei 中的营养感应和己糖激酶
- 批准号:
7454845 - 财政年份:2008
- 资助金额:
$ 29.61万 - 项目类别:
Identification of Inhibitors of Trypanosoma Brucei Hexokinases
布氏锥虫己糖激酶抑制剂的鉴定
- 批准号:
7459260 - 财政年份:2007
- 资助金额:
$ 29.61万 - 项目类别:
Glucose Sensing and Hexokinases in the African Trypanosome
非洲锥虫中的葡萄糖传感和己糖激酶
- 批准号:
9261578 - 财政年份:
- 资助金额:
$ 29.61万 - 项目类别:
相似海外基金
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
COBRE:真核病原体创新中心(EPIC)
- 批准号:
10666653 - 财政年份:2022
- 资助金额:
$ 29.61万 - 项目类别:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
COBRE:真核病原体创新中心(EPIC)
- 批准号:
10494462 - 财政年份:2022
- 资助金额:
$ 29.61万 - 项目类别:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
COBRE:真核病原体创新中心(EPIC)
- 批准号:
10666653 - 财政年份:2022
- 资助金额:
$ 29.61万 - 项目类别:
The Cell Biology of Eukaryotic Pathogens Symposium
真核病原体细胞生物学研讨会
- 批准号:
9261153 - 财政年份:2016
- 资助金额:
$ 29.61万 - 项目类别:
COBRE:Eukaryotic Pathogens Innovation Center (EPIC)
COBRE:真核病原体创新中心(EPIC)
- 批准号:
9900800 - 财政年份:2016
- 资助金额:
$ 29.61万 - 项目类别: